InvestorsHub Logo
Followers 63
Posts 8502
Boards Moderated 0
Alias Born 01/10/2014

Re: None

Sunday, 11/22/2020 11:56:35 AM

Sunday, November 22, 2020 11:56:35 AM

Post# of 197895
Why ENZC is better? The procedure for producing monoclonal antibodies is also significant and our procedure differs from those used by other pharma companies. In some cases, other pharma companies produce "humanized" rat and mouse monoclonal antibodies where the original antibody affinity and specificity are not maintained, and the chances of immunogenicity are increased. Our methodology also differs significantly from other pharma approaches using the transgenic mouse model [a human immune system which has been "grafted" within a mouse model] having been "vaccinated" with specific and selected purified CoronaVirus Proteins.

In contrast, our model starts with human "immune-B cells", obtained from convalescent individuals who have recovered from the CoronaVirus. The primary distinction of our process for creating fully human monoclonals is the starting point - namely from human "immune-B cells" from humans who have survived successfully from a "natural" CoronaVirus infection. From these, we then produce antibodies that target conserved immutable sites on the virus - to avoid "virus escape".

https://finance.yahoo.com/news/enzolytics-inc-shares-current-bioclonetics-140000939.html


“Believing in negative thoughts is the single greatest obstruction to success.”
Charles F. Glassman

Statements made are only my opinion. Do your own DD in order to make your own investment decisions.